For citations:
FDA APPROVED THE FIRST NASAL SPRAY WITH ADRENALINE TO ELIMINATE ANAPHYLAXIS. Pediatric pharmacology. 2024;21(4):385. (In Russ.)
FDA APPROVED THE FIRST NASAL SPRAY WITH ADRENALINE TO ELIMINATE ANAPHYLAXIS. Pediatric pharmacology. 2024;21(4):385. (In Russ.)